# Study to Treat Major Depressive Disorder With a New Medication

> **NCT03043560** · PHASE2 · COMPLETED · sponsor: **James Murrough** · enrollment: 45 (actual)

## Conditions studied

- Depressive Disorder
- Anhedonia

## Interventions

- **DRUG:** Ezogabine
- **DRUG:** Placebos

## Key facts

- **NCT ID:** NCT03043560
- **Lead sponsor:** James Murrough
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-09-25
- **Primary completion:** 2019-08-30
- **Final completion:** 2019-08-30
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2020-10-23

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03043560

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03043560, "Study to Treat Major Depressive Disorder With a New Medication". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03043560. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*